1676
C. B. McPake et al. / Tetrahedron Letters 50 (2009) 1674–1676
Ethyl trans-cinnamate is known to be less reactive towards epox-
(50 mL). After purging the apparatus with nitrogen, the reaction
mixture was added to NaHCO3 solution (25 mL), extracted with
CH2Cl2 (3 Â 75 mL), dried (MgSO4) and filtered. The solvent was
removed under reduced pressure to yield 2-decyloxirane (0.36 g,
98%) as a yellow oil, with no further purification required; mmax
(cmÀ1) 2923 (sp3 C–H), 2854 (sp3 C–H), 1466, 916, 833 (C–O–C),
idation processes, and our results are consistent with this observa-
tion.11 Reaction with 2 equiv of HOFÁMeCN, performed by halving
the addition rate of the alkene solution, resulted in an increase in
yield of approximately 50% as measured by 1H NMR. Cyclooctadiene
could be transformed into the corresponding di-epoxide upon reac-
tion with an excess of in situ generated HOFÁMeCN reagent.
In conclusion, we have demonstrated that HOFÁMeCN can be
generated and reacted immediately in situ in a continuous flow
microreactor channel for the efficient oxidation of alkenes, remov-
ing the need to analyse the resulting, relatively unstable
HOFÁMeCN solution. This methodology, therefore, demonstrates
that HOFÁMeCN could be used for a number of continuous flow oxi-
dations in microchannels, and given the potential for scale-out of
microreactor systems, which we have already demonstrated for
direct fluorination processes, the use of HOFÁMeCN could be
applied readily to larger scale synthesis.12
3
722; dH (400 MHz, CDCl3) 0.86 (3H, t, JHH 6.4, –CH2CH3), 1.24
(15H, m, –CH2–), 1.47 (3H, m, –CH2–), 2.43 (1H, m, OCH2), 2.71
(1H, m, OCH2), 2.87 (1H, m, CHO); dC (100 MHz, CDCl3) 14.0 (s,
CH3), 22.6, 25.9, 29.3, 29.4, 29.5, 29.6, 31.9, 32.4, 32.5 (all s, CH2),
47.0 (s, OCH2), 52.3 (s, OCH); m/z (EI) 184 ([M]+, 2%), 169
([MÀCH3]+ 100%); as compared to literature data.13
Acknowledgement
We thank AWE for funding.
References and notes
2. Experimental
1. Rozen, S.; Bareket, Y.; Kol, M. Tetrahedron 1993, 49, 8169–8178.
2. Rozen, S. Pure Appl. Chem. 1999, 71, 481–487.
3. Rozen, S. Eur. J. Org. Chem. 2005, 2433–2447.
4. Ehrfeld, W.; Hessel, V.; Lowe, H. Microreactors. New Technology for Modern
Chemistry; Wiley-VCH: New York, 2000.
5. Haswell, S. J.; Middleton, R. J.; O’Sullivan, B.; Skelton, V.; Watts, P.; Styring, P.
Chem. Commun. 2001, 391–398.
6. Chambers, R. D.; Spink, R. C. H. Chem. Commun. 1999, 883–884.
7. Chambers, R. D.; Holling, D.; Spink, R. C. H.; Sandford, G. Lab Chip 2001, 1, 132–
137.
8. Chambers, R. D.; Holling, D.; Sandford, G. U.K. Patent Application 0210809.0,
2002.
Typical procedure. CAUTION: Although 10% v/v fluorine in nitro-
gen is relatively easy to handle, it is still a potent oxidising agent
and must be treated as such. Appropriate precautions must also
be taken with regard to HF handling, including the provision of cal-
cium gluconate antidote gel.
Fluorine (10% in N2) was passed at an indicated rate of
20.0 ml minÀ1 (equating to 3.3 mmol hÀ1) into the microreactor
channel via one inlet, and simultaneously, MeCN/H2O (4:1,
10 ml) was added via syringe pump into a second inlet at a rate
9. Chambers, R. D.; Holling, D.; Rees, A. J.; Sandford, G. J. Fluorine Chem. 2003, 119,
81.
of 9.90 ml hÀ1 (110.0 mmol hÀ1
) while dodec-1-ene (0.34 g,
10. Chambers, R. D.; Fox, M. A.; Holling, D.; Nakano, T.; Okazoe, T.; Sandford, G. Lab
Chip 2005, 5, 191–198.
11. Rozen, S.; Kol, M. J. Org. Chem. 1990, 55, 5155–5159.
12. Murray, C. B.; Sandford, G. U.K. Patent Application 0816170.5, 2008.
13. Kiraz, C. I.; Altinis, M. L.; Jimenez, L. S. Synthesis 2007, 1, 92–96.
2.0 mmol) (in a 1:1 mixture of CH2Cl2/MeCN, 10 mL) was added
via syringe pump into a third inlet at a rate of 9.90 ml hÀ1. After
passage through the microreactor system, all reaction fluids were
collected in
a vessel containing dilute aq NaHCO3 solution